MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Technology Scientific & Technical Instruments

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by stealth21on Oct 18, 2012 10:39am

132 Views

Post# 20497761

RE: RE: RE: RE: RE: RE: RE: RE: RE: RE: PART 2

I like your optimism Montreal. I know YA is out of the picture thank god!!!! That's what happens when companies get desperate for financing. When do you think that 2$ is attainable? I think 0.20 for now would pave the way for 2$ in the near future.

Bullboard Posts

Cannabix advances marijuana breathalyzer tech